Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | STAT3 | P40763 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.41 |
| ▸ | NSD2 | O96028 | 3/20 | 0.34 |
| ▸ | APAF1 | O14727 | 2/20 | 0.34 |
| ▸ | TDP2 | O95551 | 2/20 | 0.34 |
| ▸ | HKDC1 | Q2TB90 | 2/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GALK1 | P51570 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.33 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triaziquone SCHEMBL21358774 | 0.91 | MAPT (0.43) | HTTMAPTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL610295 | 0.91 | DNMT1 (0.42) | HTTMAPTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL149876 | 0.90 | MAPT (0.46) | HTTMAPTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL5800741 | 0.89 | DNMT1 (0.41) | HTTMAPTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL11428634 | 0.89 | DNMT1 (0.41) | HTTMAPTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL10379983 | 0.89 | DNMT1 (0.41) | HTTMAPTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL2160619 | 0.89 | DNMT1 (0.41) | HTTMAPTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL11350903 | 0.89 | HTT (0.42) | HTTMAPTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL5606305 | 0.89 | HTT (0.42) | HTTMAPTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL2216690 | 0.88 | MAPT (0.39) | HTTMAPTTP53STAT3SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230310333-A1 | MESOPOROUS SILICA NANOPARTICLE CONTROLLED RELEASE SYSTEM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-10-05 | — | — | US | disclosed |
| EP-4209230-A1 | MESOPOROUS SILICA NANOPARTICLE CONTROLLED RELEASE SYSTEM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | East China University of Science and Technology (CN) | 2023-07-12 | — | — | EP | disclosed |
| WO-2023030459-A1 | QUINOLINONE AMIDE-CONTAINING COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | 中国科学院上海药物研究所 | 2023-03-09 | — | — | WO | disclosed |
| EP-1973587-B1 | METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS | ALLACCEM INC (US) | 2019-02-06 | — | — | EP | disclosed |
| US-9994444-B2 | Bridged polycyclic compound based compositions for the inhibition and amelioration of disease | ALLACCEM, INC. (US) | 2018-06-12 | — | — | US | disclosed |
| US-9957395-B2 | Methods and systems for coating a medical device | ALLACCEM, INC. (US) | 2018-05-01 | — | — | US | disclosed |
| US-9212286-B2 | Methods and systems for coating a surface | ALLACCEM, INC. (US) | 2015-12-15 | — | — | US | disclosed |
| EP-2125026-B1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | ALLACCEM INC (US) | 2014-09-24 | — | — | EP | disclosed |
| US-20130150809-A1 | METHODS AND SYSTEMS FOR COATING A MEDICAL DEVICE | ALLACCEM, INC. | 2013-06-13 | — | — | US | disclosed |
| US-20130040924-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | ALLACCEM, INC. (US) | 2013-02-14 | — | — | US | disclosed |
| US-20090069435-A1 | Bridged polycyclic compound based compositions for topical applications for pets | ALLACCEM, INC. | 2009-03-12 | — | — | US | disclosed |
| US-20090054528-A1 | Bridged polycyclic compound based compositions for coating oral surfaces in pets | ALLACCEM, INC. | 2009-02-26 | — | — | US | disclosed |
| US-20080275141-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | ALLACCEM, INC. | 2008-11-06 | — | — | US | disclosed |
| EP-1973587-A2 | METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS | Allaccem, Inc. (US) | 2008-10-01 | — | — | EP | disclosed |
| WO-2008103847-A2 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | ALLACCEM, INCORPORATED (US) | 2008-08-28 | — | — | WO | disclosed |
| US-20080207581-A1 | Applying to a surface one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning | ALLACCEM, INC. | 2008-08-28 | — | — | US | disclosed |
| US-20080020127-A1 | Methods and systems for coating a medical device | ALLACCEM, INC. | 2008-01-24 | — | — | US | disclosed |
| US-20080021212-A1 | Methods and systems for preparing an antimicrobial composition | ALLACCEM, INC. | 2008-01-24 | — | — | US | disclosed |
| US-20070202342-A1 | Applying to an oral surface (teeth or gums)one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning; dentistry; bonding agents, resin cements, sealants | ALLACCEM, INC. | 2007-08-30 | — | — | US | disclosed |
| WO-2007070801-A2 | METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS | ALLACCEM, INC. (US) | 2007-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069435-A1 | Bridged polycyclic compound based compositions for topical applications for pets | OTC, SLC16A8, SLC16A7 | HTT 3141/4885MAPT 1950/4885TP53 804/4885 |
| US-20090054528-A1 | Bridged polycyclic compound based compositions for coating oral surfaces in pets | PAICS, SLC16A8, CAD | HTT 3455/4885MAPT 2868/4885TP53 1199/4885 |
| US-20080021212-A1 | Methods and systems for preparing an antimicrobial composition | DNMT1, TET2, POLR1C | HTT 2528/4885MAPT 4603/4885TP53 1873/4885 |
| US-20130040924-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | PKD1, VHL, PKD2 | HTT 127/4885MAPT 1400/4885TP53 983/4885 |
| US-20080207581-A1 | Applying to a surface one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning | DNMT1, TET2, CD14 | HTT 3271/4885MAPT 4796/4885TP53 2722/4885 |
| US-20230310333-A1 | MESOPOROUS SILICA NANOPARTICLE CONTROLLED RELEASE SYSTEM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SUCNR1, GOT1, BPGM | HTT 2709/4885MAPT 3325/4885TP53 2711/4885 |
| US-20080275141-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | PKD1, VHL, PKD2 | HTT 127/4885MAPT 1400/4885TP53 983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.